Highly exuding wounds are challenging to treat. That is why we are providing a wound healing solution that clinicians want to see and that patients can feel.
Read news and updates about our company.
Mölnlycke News
May 31, 2024
EUR bond issue and tender announcement
Mölnlycke intends to issue a new 10-year EUR bond and launches a tender offer for the outstanding EUR 500m bond due February 2025.
June 5, 2024
Mölnlycke successfully prices a EUR 500M bond maturing 2034
Gothenburg, 4 June 2024: Mölnlycke, a world-leading MedTech company, has successfully raised EUR 500M in the corporate bond market under its Euro Medium...
uncategorized
May 15, 2024
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% t...
May 17, 2024
Mölnlycke announces new partnership with burn survivors organisation Phoenix Society
Mölnlycke Health Care is pleased to announce our partnership with Phoenix Society for Burn Survivors.
April 12, 2024
Mölnlycke agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke Health Care signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound...
March 28, 2024
Mölnlycke integrated Annual Report 2023
Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and plan...
February 2, 2024
Mölnlycke’s science-based targets validated
The Science Based Targets initiative (SBTi) has validated that the greenhouse gas (GHG) emission reduction targets submitted by Mölnlycke Health Care...
January 15, 2024
Mepilex Transfer Ag celebrates 10 years of providing gentle and undisturbed wound care
A decade ago, the antimicrobial foam exudate transfer dressing Mepilex® Transfer Ag was introduced as a new option for HCPs and patients in wound...
October 18, 2023
Mölnlycke® wins prestigious award for making a positive impact on society and addressing global challenges
Mölnlycke ® Health Care has been awarded the 2023 Enlightened Growth Leadership Award by The Frost & Sullivan Institute for commitment to creating a...
October 31, 2023
Cebu Surgical Medical Programme 2023 – a proof of concept for the cleft care centre of excellence
Six Mölnlycke volunteers just came back from the first Surgical Medical Programme in Cebu, the Philippines, where a cleft care centre of excellence is...
October 17, 2023
Swedish healthcare company teams up with Dutch artist to co-create art of hospital waste
Artist Maria Koijck challenged the healthcare industry with art project based on waste from own breast cancer surgery Mölnlycke Health Care responded by...
August 31, 2023
Successful 5-year Eurobond issue for Mölnlycke
Gothenburg, 31 August 2023: Mölnlycke, a world-leading medtech company, has successfully raised EUR 400M in the corporate bond market under its Euro...
September 1, 2023
Leslie McDonnell joins Mölnlycke’s Board of Directors
Leslie McDonnell has been elected Member of Mölnlycke AB’s Board of Directors on 1 September 2023.
Mölnlycke is proud to present My Mölnlycke